The second-quarter US GDP print looked, at first glance, like a disappointment: growth came in at just +1.5% annualized. But headline numbers can be poor storytellers. Strip out the noise, and the US economy is not slowing… It is accelerating where it matters most. US Q2 advanced GDP breakdown: stronger than suggested by the headline […]
The second-quarter US GDP print looked, at first glance, like a disappointment: growth came in at just +1.5% annualized. But headline numbers can be poor storytellers. Strip out the noise, and the US economy is not slowing… It is accelerating where it matters most. US Q2 advanced GDP breakdown: stronger than suggested by the headline […]
The second-quarter US GDP print looked, at first glance, like a disappointment: growth came in at just +1.5% annualized. But headline numbers can be poor storytellers. Strip out the noise, and the US economy is not slowing… It is accelerating where it matters most. US Q2 advanced GDP breakdown: stronger than suggested by the headline […]
The second-quarter US GDP print looked, at first glance, like a disappointment: growth came in at just +1.5% annualized. But headline numbers can be poor storytellers. Strip out the noise, and the US economy is not slowing… It is accelerating where it matters most. US Q2 advanced GDP breakdown: stronger than suggested by the headline […]
The second-quarter US GDP print looked, at first glance, like a disappointment: growth came in at just +1.5% annualized. But headline numbers can be poor storytellers. Strip out the noise, and the US economy is not slowing… It is accelerating where it matters most. US Q2 advanced GDP breakdown: stronger than suggested by the headline […]
In financial markets, as in society at large, AI is the current buzzword. Its promises are certainly huge and its impacts on company business models already starting to materialise across a number of sectors. What of life sciences? Could AI accelerate the drug discovery process or are the days of real-world laboratory experimenting far from […]
In financial markets, as in society at large, AI is the current buzzword. Its promises are certainly huge and its impacts on company business models already starting to materialise across a number of sectors. What of life sciences? Could AI accelerate the drug discovery process or are the days of real-world laboratory experimenting far from […]
In financial markets, as in society at large, AI is the current buzzword. Its promises are certainly huge and its impacts on company business models already starting to materialise across a number of sectors. What of life sciences? Could AI accelerate the drug discovery process or are the days of real-world laboratory experimenting far from […]
In financial markets, as in society at large, AI is the current buzzword. Its promises are certainly huge and its impacts on company business models already starting to materialise across a number of sectors. What of life sciences? Could AI accelerate the drug discovery process or are the days of real-world laboratory experimenting far from […]
In financial markets, as in society at large, AI is the current buzzword. Its promises are certainly huge and its impacts on company business models already starting to materialise across a number of sectors. What of life sciences? Could AI accelerate the drug discovery process or are the days of real-world laboratory experimenting far from […]
It’s currently hard to hold tactical convictions on markets, given the many uncertainties related to (1) the gyrations of the US-Iran war, which influence the trajectory of energy prices and, by ripple effect, the stance of monetary policy, and (2) the AI theme dominating headlines, driving dispersion within the IT sector and concentrating risk. In […]
